Published in Mol Cell Neurosci on December 23, 2012
Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct (2013) 0.92
The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun (2015) 0.87
Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure. PLoS One (2013) 0.84
New insights into immune reconstitution inflammatory syndrome of the central nervous system. Curr Opin HIV AIDS (2014) 0.82
Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target? Exp Neurol (2013) 0.82
HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism. J Neurochem (2014) 0.79
Characterization of neuropathology in the HIV-1 transgenic rat at different ages. J Neuroimmunol (2016) 0.78
Dynamic plasticity of NMDA receptor-mediated calcium entry in neurons exposed to HIV-tat. J Neurochem (2014) 0.76
HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. J Neuroinflammation (2016) 0.76
The Role of HIV Infection in Neurologic Injury. Brain Sci (2017) 0.75
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. J Neuroimmune Pharmacol (2016) 0.75
Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell (2000) 7.48
Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell (1985) 6.06
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science (2004) 5.76
Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature (2001) 5.60
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95
Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS (1996) 3.79
HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci (2007) 3.73
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron (2003) 3.62
Cadherin regulates dendritic spine morphogenesis. Neuron (2002) 3.55
NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci (2007) 3.44
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment. Neuron (2000) 3.10
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem (1999) 2.42
Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34
The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture. J Neurosci (1991) 2.31
Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J Cell Biol (1998) 2.30
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A (2000) 2.23
The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology (2004) 2.13
Cellular and molecular mechanisms of presynaptic assembly. Nat Rev Neurosci (2004) 2.04
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89
Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature (2001) 1.88
Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol (2005) 1.87
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron (2011) 1.78
NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci (2008) 1.74
Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane. EMBO J (1986) 1.73
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71
HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A (2007) 1.71
Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc Natl Acad Sci U S A (1996) 1.67
Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol (2003) 1.62
Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res (2006) 1.61
Role of Tat protein in HIV neuropathogenesis. Neurotox Res (2009) 1.60
Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol (2000) 1.46
Neurobiology of HIV. Int Rev Psychiatry (2008) 1.38
Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci (2008) 1.28
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol (2010) 1.25
The multisubunit structure of synaptophysin. Relationship between disulfide bonding and homo-oligomerization. J Biol Chem (1990) 1.20
Relative properties and localizations of synaptic vesicle protein isoforms: the case of the synaptophysins. J Neurosci (1993) 1.18
The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res (1998) 1.17
NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Mol Diagn Ther (2008) 1.05
Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol (2003) 1.05
Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death. J Neurochem (2007) 1.05
Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J Neurosci (2010) 1.01
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol Pharmacol (2011) 1.01
Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol (1994) 0.97
HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J Neuroimmune Pharmacol (2012) 0.96
Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons. J Neurosci (2011) 0.94
Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J Virol (2001) 0.93
Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol (2008) 0.93
Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol (2009) 0.92
Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br J Pharmacol (2012) 0.90
Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol (1994) 0.89
HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse (2012) 0.87
Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol (2012) 0.86
Recruitment of synaptic molecules during synaptogenesis. Neuroscientist (2001) 0.83
Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J Neurosci (2008) 1.28
Bradykinin and ATP accelerate Ca(2+) efflux from rat sensory neurons via protein kinase C and the plasma membrane Ca(2+) pump isoform 4. Neuron (2002) 1.21
Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. Mol Pharmacol (2002) 1.15
Glutamate-induced protease-mediated loss of plasma membrane Ca2+ pump activity in rat hippocampal neurons. J Neurochem (2006) 1.11
Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death. J Neurochem (2007) 1.05
Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity. J Neurosci (2010) 1.04
Transient rise in intracellular calcium produces a long-lasting increase in plasma membrane calcium pump activity in rat sensory neurons. J Neurochem (2002) 1.03
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol Pharmacol (2011) 1.01
Activation of protein kinase C in sensory neurons accelerates Ca2+ uptake into the endoplasmic reticulum. J Neurosci (2006) 0.98
Bradykinin-induced nuclear factor of activated T-cells-dependent transcription in rat dorsal root ganglion neurons. Mol Pharmacol (2007) 0.97
Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture. Neuropharmacology (2004) 0.96
NMDA-induced calcium loads recycle across the mitochondrial inner membrane of hippocampal neurons in culture. J Neurophysiol (2002) 0.92
Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol Pharmacol (2009) 0.92
Altered distribution of mitochondria impairs calcium homeostasis in rat hippocampal neurons in culture. J Neurochem (2003) 0.92
Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res (2006) 0.91
Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol (2004) 0.91
Mitochondrial modulation of Ca2+ -induced Ca2+ -release in rat sensory neurons. J Neurophysiol (2006) 0.89
Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture. J Pharmacol Exp Ther (2008) 0.87
Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate. Mol Pharmacol (2008) 0.87
HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways. J Neurochem (2014) 0.86
Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol (2012) 0.86
gamma-Secretase activity modulates store-operated Ca2+ entry into rat sensory neurons. Neurosci Lett (2008) 0.85
Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture. J Neurosci (2013) 0.84
Delta(9)-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture. Neuropharmacology (2005) 0.83
Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice. Skelet Muscle (2011) 0.82
Inhibition of the plasma membrane Ca2+ pump by CD44 receptor activation of tyrosine kinases increases the action potential afterhyperpolarization in sensory neurons. J Neurosci (2011) 0.82
Cannabinoids throw up a conundrum. Br J Pharmacol (2002) 0.81
Ca2+-dependent, stimulus-specific modulation of the plasma membrane Ca2+ pump in hippocampal neurons. J Neurophysiol (2009) 0.80
HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism. J Neurochem (2014) 0.79
NMDA-evoked consumption and recovery of mitochondrially targeted aequorin suggests increased Ca2+ uptake by a subset of mitochondria in hippocampal neurons. Brain Res (2003) 0.78
Epileptiform stimulus increases Homer 1a expression to modulate synapse number and activity in hippocampal cultures. J Neurophysiol (2012) 0.78
Homer proteins accelerate Ca2+ clearance mediated by the plasma membrane Ca2+ pump in hippocampal neurons. Biochem Biophys Res Commun (2012) 0.78
Epileptic stimulus increases Homer 1a expression to modulate endocannabinoid signaling in cultured hippocampal neurons. Neuropharmacology (2012) 0.78